Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Demirkazik

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Bone Marrow Transplantation|August 18, 2001
Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantationA Demirkazik, A Kessinger, J O Armitage, et al.
The International Journal of Biological Markers|February 17, 2017
The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospectivematched-paired studyM Dogan, A Demirkazik, N Konuk, et al.
Cancer|January 5, 1999
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology GroupF Içli, I Celik, F Aykan, et al.
The International Journal of Biological Markers|December 21, 2006
The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired studyM Dogan, A Demirkazik, N Konuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancerF Içli, H Akbulut, D Dinçol, et al.
European Journal of Cancer Care|January 10, 2008
The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinomaO Sencan, A Buyukcelik, B Yalcin, et al.
Cancer|May 17, 2000
Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcomaD Dinçol, M Samur, A Pamir, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 4, 2012
ABO and Rh blood groups frequency in women with HER2 positive breast cancerY Urun, G Utkan, K Altundag, et al.
British Journal of Cancer|February 24, 2005
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology GroupF Icli, H Akbulut, A Uner, et al.
Tuberkuloz Ve Toraks|December 29, 2009
The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey)A Yorgancioğlu, H Türktaş, O Kalayci, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Bone Marrow Transplantation|August 18, 2001
Progenitor and lymphoma cells in blood stem cell harvests: impact on survival following transplantationA Demirkazik, A Kessinger, J O Armitage, et al.
The International Journal of Biological Markers|February 17, 2017
The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospectivematched-paired studyM Dogan, A Demirkazik, N Konuk, et al.
Cancer|January 5, 1999
A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. Turkish Oncology GroupF Içli, I Celik, F Aykan, et al.
The International Journal of Biological Markers|December 21, 2006
The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired studyM Dogan, A Demirkazik, N Konuk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
A randomized trial of four cycles of adjuvant AC (adriamycin + cyclophosphamide) +/- two cycles of EP (etoposide + cisplatin) in node positive patients with breast cancerF Içli, H Akbulut, D Dinçol, et al.
European Journal of Cancer Care|January 10, 2008
The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinomaO Sencan, A Buyukcelik, B Yalcin, et al.
Cancer|May 17, 2000
Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcomaD Dinçol, M Samur, A Pamir, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 4, 2012
ABO and Rh blood groups frequency in women with HER2 positive breast cancerY Urun, G Utkan, K Altundag, et al.
British Journal of Cancer|February 24, 2005
Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology GroupF Icli, H Akbulut, A Uner, et al.
Tuberkuloz Ve Toraks|December 29, 2009
The WHO global alliance against chronic respiratory diseases in Turkey (GARD Turkey)A Yorgancioğlu, H Türktaş, O Kalayci, et al.
Pageof 3